Evidence map›Paper›PMID 39215123›Full record

ArticleScientific reports2024

Rapid identification of antibody impurities in size-based electrophoresis via CZE-MS generated spectral library.

Quan Liu, Jiaying Hong, Yukun Zhang, Qiuyue Wang, Qiangwei Xia, Michael D Knierman, Jim Lau, Caleen Dayaratna, Benjamin Negron, Hirsh Nanda and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Quan Liu *CMP Scientific Corp, 760 Parkside Ave, STE 211, Brooklyn, NY, 11226, USA.
Jiaying Hong *CMP Scientific Corp, 760 Parkside Ave, STE 211, Brooklyn, NY, 11226, USA.
Yukun ZhangCMP Scientific Corp, 760 Parkside Ave, STE 211, Brooklyn, NY, 11226, USA.
Qiuyue WangCMP Scientific Corp, 760 Parkside Ave, STE 211, Brooklyn, NY, 11226, USA.
Qiangwei XiaCMP Scientific Corp, 760 Parkside Ave, STE 211, Brooklyn, NY, 11226, USA.
Michael D KniermanAgilent Technologies, 5301 Stevens Creek Blvd, Santa Clara, CA, 95051, USA.
Jim LauAgilent Technologies, 5301 Stevens Creek Blvd, Santa Clara, CA, 95051, USA.
Caleen DayaratnaJohnson & Johnson Innovative Medicine Research & Development, 1400 McKean Road, Spring House, PA, 19477, USA.
Benjamin NegronJohnson & Johnson Innovative Medicine Research & Development, 1400 McKean Road, Spring House, PA, 19477, USA.
Hirsh NandaJohnson & Johnson Innovative Medicine Research & Development, 1400 McKean Road, Spring House, PA, 19477, USA.
Harsha P GunawardenaJohnson & Johnson Innovative Medicine Research & Development, 1400 McKean Road, Spring House, PA, 19477, USA. hgunawar@ITS.JNJ.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methods for the reliable and effective detection and identification of impurities are crucial to ensure the quality and safety of biopharmaceutical products. Technical limitations constrain the accurate identification of individual impurity peaks by size-based electrophoresis separations followed by mass spectrometry. This study presents a size-based electrophoretic method for detecting and identifying impurity peaks in antibody production. A hydrogen sulfide-accelerated degradation method was employed to generate known degradation products observed in bioreactors that forms the basis for size calibration. LabChip GXII channel electrophoresis enabled the rapid (< 1 min) detection of impurity peaks based on size, while capillary zone electrophoresis-mass spectrometry (CZE-MS) facilitated their accurate identification. We combine these techniques to examine impurities resulting from cell culture harvest conditions and forced degradation to assess antibody stability. To mimic cell culture harvest conditions and the impact of forced degradation, we subjected samples to cathepsin at different pH buffers or exposed them to high pH and temperature. Our method demonstrated the feasibility and broad applicability of using a CZE-MS generated spectral library to unambiguously assign peaks in high throughput size-based electrophoresis (i.e., LabChip GXII) with identifications or likely mass of the antibody impurity. Overall, this strategy combines the utility of CZE-MS as a high-resolution separation and detection method for impurities with size-based electrophoresis methods that are typically used to detect (not identify) impurities during the discovery and development of antibody therapeutics.

Indexed as

Drug ContaminationElectrophoresis, CapillaryMass SpectrometryAnimalsAntibodies, MonoclonalBioreactorsCathepsinsCHO CellsCricetulusHydrogen-Ion ConcentrationAntibodies, MonoclonalCathepsinsAntibodyCE-SDSCZE-MSDegradationImpurityLabChip

Identifiers

PMID39215123
PMCPMC11364755

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.